Isosorbide mononitrate indications and usage: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Isosorbide mononitrate#Adult Indications and Dosage]]
{{Isosorbide mononitrate
}}
{{CMG}}; {{AE}} {{PB}}
 
Isosorbide mononitrate extended-release tablets are indicated for the prevention of [[angina pectoris]] due to [[coronary artery disease]]. The onset of action of oral ISMN is not sufficiently rapid for this product to be useful in aborting an acute angina episode.
 
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ISOSORBIDE MONONITRATE TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=897a0327-25d4-4769-bd6a-0e674264017f | publisher =  | date =  | accessdate = 30 January 2014 }}</ref>
 
==References==
 
{{Reflist|2}}
 
[[Category:Drugs]]

Latest revision as of 22:42, 21 July 2014

Redirect to:

Retrieved from "https://www.wikidoc.org/index.php?title=Isosorbide_mononitrate_indications_and_usage&oldid=997588"